Drug General Information
Drug ID
D0G8LN
Former ID
DCL001202
Drug Name
ISIS-SGLT2
Drug Type
Antisense drug
Indication Type 2 diabetes [ICD9: 250; ICD10:E11] Phase 1 [551052]
Company
ISIS Pharm
Target and Pathway
Target(s) mRNA of sodium-glucosetransporter-2 Target Info [551052]
Reactome Hexose transport
Na+-dependent glucose transporters
Inositol transporters
WikiPathways NRF2 pathway
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds
References
Ref 551052Clinical pipeline report, company report or official report of ISIS Pharmaceuticals (2011).
Ref 551052Clinical pipeline report, company report or official report of ISIS Pharmaceuticals (2011).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.